Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human CD106/VCAM1 Nanobody (SAA2055)

Catalog #:   RHD33101 Specific References (14) DATASHEET
Host species: Alpaca
Isotype: VHH-8His-Cys-tag
Applications: ELISA
Expression system: Mammalian Cells
Overview

Catalog No.

RHD33101

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Alpaca

Isotype

VHH-8His-Cys-tag

Clonality

Monoclonal

Target

Vascular cell adhesion protein 1, VCAM1, CD106, INCAM-100, V-CAM 1, VCAM-1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Purified by Nickel column.

Accession

P19320

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA2055

Data Image
  • SDS-PAGE
    SDS PAGE for Human CD106/VCAM1 Nanobody (SAA2055)
References

Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody., PMID:36828835

VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques., PMID:33138124

Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging., PMID:32316285

Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery., PMID:32167754

Ultrasound Molecular Imaging of Atherosclerosis With Nanobodies: Translatable Microbubble Targeting Murine and Human VCAM (Vascular Cell Adhesion Molecule) 1., PMID:31597443

Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis., PMID:30343086

Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis - impact of radiochemistry on pharmacokinetics., PMID:30240352

Enhanced Biosensor Platforms for Detecting the Atherosclerotic Biomarker VCAM1 Based on Bioconjugation with Uniformly Oriented VCAM1-Targeting Nanobodies., PMID:27399790

Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques., PMID:26800768

An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation., PMID:26243885

Molecular imaging of rheumatoid arthritis: emerging markers, tools, and techniques., PMID:25099015

Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions., PMID:22461363

Over a hump for imaging atherosclerosis: nanobodies visualize vascular cell adhesion molecule-1 in inflamed plaque., PMID:22461358

Nanobody-coupled microbubbles as novel molecular tracer., PMID:22197777

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CD106/VCAM1 Nanobody (SAA2055) [RHD33101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only